CompletedPhase 3NCT00876031
Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
Studying OBSOLETE: Pleomorphic undifferentiated sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Tuebingen
- Principal Investigator
- Ewa Koscielniak, MDOlgahospital, CWS
- Intervention
- trofosfamide, idarubicin, etoposide(drug)
- Enrollment
- 195 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2009 – 2022
Study locations (30)
- Krankenhaus der Stadt Dornbirn, Dornbirn, Austria
- Universitätsklinik für Kinder- und Jugendheilkunde, Graz, Austria
- Universitätsklinik für Kinder- und Jugendheilkunde, Innsbruck, Austria
- Landeskrankenhaus, Klagenfurt, Austria
- Landeskrankenhaus, Leoben, Austria
- Landesfrauen - und Kinderklinik Linz, Linz, Austria
- St. Johanns Spital / Landeskrankenhaus, Salzburg, Austria
- St. Anna Kinderspital, Vienna, Austria
- Universitätsklinikum, Aachen, Germany
- Klinikum Augsburg, Augsburg, Germany
- Charité, Berlin, Germany
- Helios Klinikum Berlin-Buch, Berlin, Germany
- Krankenhaus Bielefeld, Bielefeld, Germany
- Universitätskinderklinik, Bonn, Germany
- Klinikum Braunschweig, Braunschweig, Germany
- +15 more locations on ClinicalTrials.gov
Collaborators
Cooperative Weichteilsarkom Study Group · Deutsche Kinderkrebsstiftung · German Society for Pediatric Oncology and Hematology GPOH gGmbH · Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria · The Swedish Childhood Solid Tumor Working Group · Polish Paediatric Solid Tumours Study Group · Swiss Pediatric Oncology Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00876031 on ClinicalTrials.govOther trials for OBSOLETE: Pleomorphic undifferentiated sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07049848SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue SarcomaM.D. Anderson Cancer Center
- ACTIVE NOT RECRUITINGPHASE1NCT05813327Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue SarcomaWashington University School of Medicine
- ACTIVE NOT RECRUITINGNANCT05776667Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue SarcomaMedical University of South Carolina
- RECRUITINGNANCT05944913Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After RadiotherapyCentre Leon Berard
- RECRUITINGPHASE3NCT05597917tTF-NGR Randomized Study - STSUniversität Münster
- RECRUITINGNANCT04946357Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With IonsUniversity Hospital Heidelberg
See all trials for OBSOLETE: Pleomorphic undifferentiated sarcoma →